Hefei Lifeon Pharmaceutical Co Ltd (003020) - Total Liabilities
Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has total liabilities worth CN¥652.24 Million CNY (≈ $95.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003020 cash generation efficiency to assess how effectively this company generates cash.
Hefei Lifeon Pharmaceutical Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Hefei Lifeon Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Hefei Lifeon Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Leong Hup International Berhad
KLSE:6633
|
Malaysia | RM2.97 Billion |
|
Xiamen Sunrise Wheel Group Co Ltd
SHE:002593
|
China | CN¥2.27 Billion |
|
Ningbo Bohui Chemical Technology
SHE:300839
|
China | CN¥992.02 Million |
|
Vivakor Inc
NASDAQ:VIVK
|
USA | $96.09 Million |
|
Xinjiang Ba Yi Iron & Steel Co Ltd
SHG:600581
|
China | CN¥29.36 Billion |
|
EirGenix
TWO:6589
|
Taiwan | NT$1.94 Billion |
|
APG SGA SA
SW:APGN
|
Switzerland | CHF93.01 Million |
|
Shanghai Yimin Commerce Group Co Ltd
SHG:600824
|
China | CN¥419.03 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Hefei Lifeon Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Hefei Lifeon Pharmaceutical Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hefei Lifeon Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hefei Lifeon Pharmaceutical Co Ltd (2012–2024)
The table below shows the annual total liabilities of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥673.38 Million ≈ $98.54 Million |
+10.36% |
| 2023-12-31 | CN¥610.18 Million ≈ $89.29 Million |
-4.89% |
| 2022-12-31 | CN¥641.53 Million ≈ $93.88 Million |
+73.14% |
| 2021-12-31 | CN¥370.53 Million ≈ $54.22 Million |
+2.35% |
| 2020-12-31 | CN¥362.03 Million ≈ $52.98 Million |
+20.75% |
| 2019-12-31 | CN¥299.82 Million ≈ $43.87 Million |
+13.01% |
| 2018-12-31 | CN¥265.31 Million ≈ $38.82 Million |
+5.64% |
| 2017-12-31 | CN¥251.14 Million ≈ $36.75 Million |
+0.57% |
| 2016-12-31 | CN¥249.71 Million ≈ $36.54 Million |
-4.00% |
| 2014-12-31 | CN¥260.11 Million ≈ $38.06 Million |
-3.43% |
| 2013-12-31 | CN¥269.34 Million ≈ $39.41 Million |
+24.31% |
| 2012-12-31 | CN¥216.67 Million ≈ $31.71 Million |
-- |
About Hefei Lifeon Pharmaceutical Co Ltd
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethy… Read more